Clinical trial NCT04374643: Descriptive Study of the PSYchological Impact of CONFinement Measures in the General Population
Official title: Descriptive Study of the PSYchological Impact of CONFinement Measures in the General Population : PsyConfPop
Study type: OBSERVATIONAL
Overall status: UNKNOWN
Conditions: Depression
COVID 19
Keywords: Confinement
Depression
Post traumatic stress
Adults
Lead sponsor: University Hospital, Montpellier
Sponsor class: OTHER
First posted: 2020-05-05
Enrollment: 500
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: yes
Observational model: COHORT
Time perspective: PROSPECTIVE
Sampling method: PROBABILITY_SAMPLE
Study population: Adults who agree to participate by answering the questionnaires

Brief summary: Quarantine is an unpleasant experience : separation from loved ones, loss of freedom, uncertainty about infection status, boredom. It may lead to negative mental health consequences and thus the emergence of anxiety and depressive symptoms.

From March 17th, 2020 to May 11th 2002, the French government has implemented national containment measures due to the Covid-19 epidemic.

Although there are data on the psychological impact and experience of quarantine measures in people who have been infected or suspected of being carriers of certain pathogens (e.g. Ebola), there are no data on such impact in the French population and quarantines lasting longer than 21 days. Investigators therefore propose to conduct a human and social sciences study in order to better understand the current situation

Detailed description: The main objective is to describe the psychological state during confinement (and the impact of the confinement) in a sample of the French general population.

Secondary objectives :

* to assess the evolution of psychological health between the period of confinement and post-confinement.
* to identify clinical factors modulating psychological state during confinement

It is expected to highlight :

* a link between the intensity of anxiety symptoms and the number/quality of social contacts
* a reduction of anxiety and depression symptoms in the post-confinement period.
* higher consumption of drugs during the confinement period

Self-questionnaires (Google form format) are sent by mailing lists or social networks to participants in order to complete the assessment of psychological state. A unique identifier is sent in a separate email. These assessments are performed at least once during the confinement period. It is planned to repeat them when the confinement is lifted: 15 days, 3 and 6 months after the lifting of the confinement because of the risk of developing anxiodepressive symptoms, in particular post-traumatic stressors.

Eligibility criteria: Inclusion criteria:

- age\> 18

Exclusion criteria:

- protective measure (curatorship, guardianship)

Primary outcomes:
measure: Depressive Symptomatology
timeFrame: during confinement
Secondary outcomes:
measure: Depressive Symptomatology
timeFrame: post-confinement : 15 days, 3 months, 6 months
Other outcomes:
measure: Psychological pain
timeFrame: during confinement
measure: sleep
timeFrame: during confinement
measure: sleep
timeFrame: post-confinement (15 days, 3 months, 6 months)
measure: anxiety
timeFrame: during confinement
measure: anxiety
timeFrame: post-confinement (15 days, 3 months, 6 months)
measure: psychological pain
timeFrame: post-confinement (15 days, 3 months, 6 months)
measure: physical pain
timeFrame: during confinement
measure: physical pain
timeFrame: post-confinement (15 days, 3 months, 6 months)
measure: anger
timeFrame: during confinement
measure: anger
timeFrame: post-confinement (15 days, 3 months, 6 months)
measure: Stressful Event Impact
timeFrame: during confinement
measure: Stressful Event Impact
timeFrame: post-confinement (15 days, 3 months, 6 months)
measure: Use of psychotropic drugs
timeFrame: during confinement
measure: Use of psychotropic drugs
timeFrame: post-confinement (15 days, 3 months, 6 months)
measure: Tobacco consumption
timeFrame: during confinement
measure: Tobacco consumption
timeFrame: post-confinement (15 days, 3 months, 6 months)
measure: alcohol consumption
timeFrame: post-confinement (15 days, 3 months, 6 months)
measure: alcohol consumption
timeFrame: confinement
measure: Illicit substances consumption
timeFrame: confinement
measure: Illicit substances consumption
timeFrame: post-confinement (15 days, 3 months, 6 months)
measure: orientation of life
timeFrame: confinement
measure: orientation of life
timeFrame: post-confinement (15 days, 3 months, 6 months)
Locations:
city: Montpellier
country: France
facility: University hospital
Study officials:
affiliation: University Hospital, Montpellier
name: Emilie Olie, MD PhD
role: PRINCIPAL_INVESTIGATOR
References: